Fresenius Sustainability Profile
Fresenius SE & Co. KGaA, commonly referred to as Fresenius, is a global healthcare group headquartered in Bad Homburg, Germany. Founded in 1912, the company has established itself as a leader in the healthcare industry, with significant operations across Europe, North America, and Asia. Fresenius operates primarily in the fields of dialysis, hospital management, and medical devices, providing innovative solutions that enhance patient care. The company’s core offerings include dialysis products and services through Fresenius Medical Care, as well as pharmaceuticals and clinical nutrition via Fresenius Kabi. Known for its commitment to quality and patient-centric solutions, Fresenius has achieved notable milestones, including being a key player in the global dialysis market. With a strong market position and a reputation for excellence, Fresenius continues to drive advancements in healthcare, making a meaningful impact on patients' lives worldwide.
DitchCarbon Score
How does Fresenius's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fresenius's score of 69 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fresenius's reported carbon emissions
In 2024, Fresenius reported total carbon emissions of approximately 4,199,000,000 kg CO2e, with Scope 1 emissions at about 351,000,000 kg CO2e, Scope 2 emissions (market-based) at approximately 165,000,000 kg CO2e, and Scope 3 emissions reaching about 3,683,000,000 kg CO2e. The previous year, 2023, saw total emissions of about 4,222,000,000 kg CO2e, with Scope 1 at approximately 344,000,000 kg CO2e and Scope 2 (market-based) at around 215,000,000 kg CO2e. Fresenius has set ambitious climate commitments, aiming for climate neutrality by 2040. The company plans to reduce its absolute Scope 1 and Scope 2 emissions by 50% by 2030, using 2020 as the baseline year. Additionally, Fresenius Medical Care, a subsidiary, is targeting near-zero emissions for Scope 1 and 2 by 2025, with a 30% reduction in Scope 2 emissions from the 2020 baseline by 2030. These commitments reflect Fresenius's proactive approach to addressing climate change, aligning with industry standards and expectations for sustainability. The emissions data and reduction targets are sourced from Fresenius SE & Co. KGaA, the parent company, ensuring a comprehensive view of the organisation's environmental impact and initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 521,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 1,013,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Fresenius's Industry?
How Carbon Intensive is Fresenius's Location?
Fresenius's Scope 3 Categories Breakdown
Fresenius's Scope 3 emissions, which increased by 1% last year and increased by approximately 1% since 2023, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 44% of Scope 3 emissions.
Top Scope 3 Categories
Fresenius's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Fresenius has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
